|
| Moritz Gerstung | Wellcome Trust Sanger Institute (E.P., and the European Bioinformatics Institute, Institute of Cancer Research, University of Cambridge, the Center for Molecular Oncology and the Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, Ulm University, Hannover Medical School, Fondazione IRCCS, Istituto Nazionale dei Tumori, University of Milan, University of Leuven, University of Otago |
| Michael Heuser | Wellcome Trust Sanger Institute (E.P., and the European Bioinformatics Institute, Institute of Cancer Research, University of Cambridge, the Center for Molecular Oncology and the Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, Ulm University, Hannover Medical School, Fondazione IRCCS, Istituto Nazionale dei Tumori, University of Milan, University of Leuven, University of Otago |
| Felicitas Thol | Wellcome Trust Sanger Institute (E.P., and the European Bioinformatics Institute, Institute of Cancer Research, University of Cambridge, the Center for Molecular Oncology and the Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, Ulm University, Hannover Medical School, Fondazione IRCCS, Istituto Nazionale dei Tumori, University of Milan, University of Leuven, University of Otago |
| Gunes Gundem | Wellcome Trust Sanger Institute (E.P., and the European Bioinformatics Institute, Institute of Cancer Research, University of Cambridge, the Center for Molecular Oncology and the Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, Ulm University, Hannover Medical School, Fondazione IRCCS, Istituto Nazionale dei Tumori, University of Milan, University of Leuven, University of Otago |
| Peter Van Loo | Wellcome Trust Sanger Institute (E.P., and the European Bioinformatics Institute, Institute of Cancer Research, University of Cambridge, the Center for Molecular Oncology and the Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, Ulm University, Hannover Medical School, Fondazione IRCCS, Istituto Nazionale dei Tumori, University of Milan, University of Leuven, University of Otago |
| Inigo Martincorena | Wellcome Trust Sanger Institute (E.P., and the European Bioinformatics Institute, Institute of Cancer Research, University of Cambridge, the Center for Molecular Oncology and the Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, Ulm University, Hannover Medical School, Fondazione IRCCS, Istituto Nazionale dei Tumori, University of Milan, University of Leuven, University of Otago |
| Laura Mudie | Wellcome Trust Sanger Institute (E.P., and the European Bioinformatics Institute, Institute of Cancer Research, University of Cambridge, the Center for Molecular Oncology and the Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, Ulm University, Hannover Medical School, Fondazione IRCCS, Istituto Nazionale dei Tumori, University of Milan, University of Leuven, University of Otago |
| Stuart McLaren | Wellcome Trust Sanger Institute (E.P., and the European Bioinformatics Institute, Institute of Cancer Research, University of Cambridge, the Center for Molecular Oncology and the Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, Ulm University, Hannover Medical School, Fondazione IRCCS, Istituto Nazionale dei Tumori, University of Milan, University of Leuven, University of Otago |
| Sarah O'Meara | Wellcome Trust Sanger Institute (E.P., and the European Bioinformatics Institute, Institute of Cancer Research, University of Cambridge, the Center for Molecular Oncology and the Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, Ulm University, Hannover Medical School, Fondazione IRCCS, Istituto Nazionale dei Tumori, University of Milan, University of Leuven, University of Otago |
| Keiran Raine | Wellcome Trust Sanger Institute (E.P., and the European Bioinformatics Institute, Institute of Cancer Research, University of Cambridge, the Center for Molecular Oncology and the Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, Ulm University, Hannover Medical School, Fondazione IRCCS, Istituto Nazionale dei Tumori, University of Milan, University of Leuven, University of Otago |
| David Jones | Wellcome Trust Sanger Institute (E.P., and the European Bioinformatics Institute, Institute of Cancer Research, University of Cambridge, the Center for Molecular Oncology and the Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, Ulm University, Hannover Medical School, Fondazione IRCCS, Istituto Nazionale dei Tumori, University of Milan, University of Leuven, University of Otago |
| Jon Teague | Wellcome Trust Sanger Institute (E.P., and the European Bioinformatics Institute, Institute of Cancer Research, University of Cambridge, the Center for Molecular Oncology and the Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, Ulm University, Hannover Medical School, Fondazione IRCCS, Istituto Nazionale dei Tumori, University of Milan, University of Leuven, University of Otago |
| Adam Butler | Wellcome Trust Sanger Institute (E.P., and the European Bioinformatics Institute, Institute of Cancer Research, University of Cambridge, the Center for Molecular Oncology and the Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, Ulm University, Hannover Medical School, Fondazione IRCCS, Istituto Nazionale dei Tumori, University of Milan, University of Leuven, University of Otago |
| Peter J Campbell | Wellcome Trust Sanger Institute (E.P., and the European Bioinformatics Institute, Institute of Cancer Research, University of Cambridge, the Center for Molecular Oncology and the Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, Ulm University, Hannover Medical School, Fondazione IRCCS, Istituto Nazionale dei Tumori, University of Milan, University of Leuven, University of Otago |